1 / 4

Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Growth, Demand, Price and Forecasts To 2020

GlobalData's Medical Devices sector report, "Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Medical Devices Pipeline Assessment, 2016" provides an overview of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) currently in pipeline stage.

Hexareports
Download Presentation

Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Growth, Demand, Price and Forecasts To 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hexa Reports Market Research Reports and Insightful Company Profiles Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Size, Share, Strategies, Global Insights, Analysis and Forecasts 2016 Summary GlobalData's Medical Devices sector report, "Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Medical Devices Pipeline Assessment, 2016" provides an overview of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Browse Detail Report With TOC@ http://www.hexareports.com/report/peripheral-transluminal- angioplasty-peripheral-drug-eluting-balloons-deb-medical-devices-pipeline-assessment-2016/details Scope

  2. Hexa Reports Market Research Reports and Insightful Company Profiles - Extensive coverage of the Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons To Buy The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage - Identify and understand important and diverse types of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Request A Sample copy of This Report @ http://www.hexareports.com/sample/159330 Table Of Content 1 Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 7 2 Introduction 8 2.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) Overview 8 3 Products under Development 9 3.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development 9 3.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Territory 10 3.3 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path 11 3.4 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date 12

  3. Hexa Reports Market Research Reports and Insightful Company Profiles 3.5 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Ongoing Clinical Trials 13 4 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Pipeline Products under Development by Companies 14 4.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) Companies - Pipeline Products by Stage of Development 14 4.2 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development 15 5 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (DEB) Companies and Product Overview 16 5.1 AnGes MG, Inc. Company Overview 16 5.1.1 AnGes MG, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16 5.2 AngioCure, Inc. Company Overview 18 5.2.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18 5.3 AVIDAL Vascular GmbH Company Overview 19 5.3.1 AVIDAL Vascular GmbH Pipeline Products & Ongoing Clinical Trials Overview 19 5.4 Bayer HealthCare AG Company Overview 20 5.4.1 Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview 20 5.5 Contego Medical, LLC Company Overview 22 5.5.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 22 5.6 Elixir Medical Corporation Company Overview 23 5.6.1 Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 23 5.7 eucatech AG Company Overview 24 5.7.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 24 5.8 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 25 5.8.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25 5.9 Medtronic plc Company Overview 26 5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 26 5.10 Micell Technologies, Inc. Company Overview 28 5.10.1 Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28 5.11 Nipro Corporation Company Overview 30 5.11.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 30 5.12 NuVascular Technologies Inc Company Overview 31 5.12.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 31 5.13 QT Vascular Ltd. Company Overview 32 5.13.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32 5.14 QualiMed Innovative Medizinprodukte GmbH Company Overview 36 5.14.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 36 5.15 Rontis AG Company Overview 37 5.15.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 37 5.16 SiL Vascular Ltd Company Overview 38

  4. Hexa Reports Market Research Reports and Insightful Company Profiles 5.16.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 38 5.17 SurModics, Inc. Company Overview 39 5.17.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39 5.18 Terumo Corporation Company Overview 44 5.18.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 44 5.19 The Spectranetics Corporation Company Overview 46 5.19.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 46 5.20 Vascular Nanotransfer Technologies Company Overview 52 5.20.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 52 Browse Full Report @ http://www.hexareports.com/report/peripheral-transluminal-angioplasty- peripheral-drug-eluting-balloons-deb-medical-devices-pipeline-assessment-2016/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in

More Related